Benefits of Short-Term (4-Week) Daily Walnut Consumption in Middle-Aged Adults at Risk for Metabolic Syndrome: Outcomes of a Randomized Controlled Trial
Authors:
- Letiția MateșLMLetiția Mateș
- Doina Albert-AniDADoina Albert-Ani
- Ionel FizeșanIonel Fizeșan
- Andreea-Elena PetruAPAndreea-Elena Petru
- Roxana BancRBRoxana Banc
- Marius Emil RusuMarius Emil Rusu
- Carmen CostacheCCCarmen Costache
- Lorena FilipLFLorena Filip
- Daniela-Saveta PopaDaniela-Saveta Popa
- Daniel-Corneliu LeucuțaDLDaniel-Corneliu Leucuța
Open Access
Abstract
Background: Epidemiological research has shown that regular walnut (from Juglans regia L.) consumption is associated with a reduced risk of cardiovascular disease (CVD), potentially attributable to their antioxidant and anti-inflammatory properties. The vascular cellular adhesion molecule-1 (VCAM-1), a protein upregulated in CVD, has been previously examined in relation to walnut consumption. However, the clinical findings regarding the effects of walnuts on endothelial function among middle-aged individuals susceptible to metabolic syndrome (MetS) remain inconclusive. Objective: This study examined the effects of daily walnut consumption over a four-week period on cardiometabolic parameters (lipid and glycemic profiles, as well as soluble VCAM-1 levels) and anthropometric measurements in middle-aged individuals with at least one altered MetS parameter and no medication. Methods: In a randomized controlled cross-over trial, 22 eligible Caucasian participants (48.81 ± 4.3 years) were selected and randomly assigned to receive either 45 g of walnuts per day or no walnuts within a controlled diet. There were two 28-day intervention periods, with a one-month washout period in between. Clinical and biochemical evaluations were conducted at the beginning and end of each intervention period. Results: A total of 20 participants completed the intervention and were analyzed, with walnuts being well tolerated. A significant decrease in waist circumference (p = 0.049) and a slight change in fasting blood glucose (p = 0.089) were noted following walnut intake. Conclusions: Short-term (4 weeks) dietary supplementation with walnuts resulted in a statistically significant reduction in waist circumference while not impacting the overall health status of participants. Longer-term studies are necessary to investigate the benefits of daily walnut consumption and its impact on the onset and development of MetS in this age group.Keywords
Funding Information
- Iuliu Hațieganu University of Medicine and Pharmacy (771/42/11)
This publication has 62 references indexed in Scilit:
- Effect of walnut consumption on markers of endothelial function in adults: A systematic review and meta‐analysis of randomized controlled trialsPhytotherapy Research, 2024
- Association of Tree Nut Consumption with Cardiovascular Disease and Cardiometabolic Risk Factors and Health Outcomes in US Adults: NHANES 2011–2018Current Developments in Nutrition, 2023
- Tree Nut and Peanut Consumption and Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsAdvances in Nutrition, 2023
- VCAM-1 as a predictor biomarker in cardiovascular diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2021
- Effects of 2-Year Walnut-Supplemented Diet on Inflammatory BiomarkersJACC, 2020
- Effects of walnut intake on blood pressure: A systematic review and meta‐analysis of randomized controlled trialsPhytotherapy Research, 2020
- Effects of walnut intake on anthropometric characteristics: A systematic review and dose-response meta-analysis of randomized controlled trialsComplementary Therapies in Medicine, 2020
- Soluble ICAM 1 and VCAM 1 Blood Levels Alert on Subclinical Atherosclerosis in Non Smokers with Asymptomatic Metabolic SyndromeArchives of Medical Research, 2019
- Acute effects of diets rich in almonds and walnuts on endothelial functionIndian Heart Journal, 2018
- Acute Effects of High-Fat Meals Enriched With Walnuts or Olive Oil on Postprandial Endothelial FunctionJACC, 2006